Cargando…

Hepatic osteodystrophy with hypophosphataemia and elevated fibroblast growth factor‐23

Detalles Bibliográficos
Autores principales:	Ng, Nicholas Beng Hui, Karthik, S Venkatesh, Lee, Yung Seng, Aw, Marion M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd. 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790692/ https://www.ncbi.nlm.nih.gov/pubmed/35486438 http://dx.doi.org/10.1111/jpc.16001

Ejemplares similares

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Rickety Osteodystrophy
Publicado: (1935)

Osteodystrophies of jaws
por: Santana, N, et al.
Publicado: (2020)

Burosumab for X-linked hypophosphataemia
Publicado: (2021)

New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy
por: Krintus, Magdalena, et al.
Publicado: (2004)

Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development
por: Ehnert, Sabrina, et al.
Publicado: (2019)

Severe hypophosphataemia after intravenous iron administration
por: Anand, Gurpreet, et al.
Publicado: (2017)

Isolated hypophosphataemia as an early marker of primary hyperparathyroidism
por: Alexander, John, et al.
Publicado: (2021)

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
por: Wang, Joseph, et al.
Publicado: (2017)

Osteodystrophy from Cattle Disease
Publicado: (1931)

Parathyreoid Osteodystrophy (Osteitis Fibrosa)
por: Struthers, J. W.
Publicado: (1933)

Post-Traumatic Osteodystrophy at Joints
por: Middleton, D. Stewart, et al.
Publicado: (1934)

The Role of Serum Cytokines in the Pathogenesis of Hepatic Osteodystrophy in Male Cirrhotic Patients
por: Soylu, Ali Riza, et al.
Publicado: (2012)

Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension
por: Lin, Yao, et al.
Publicado: (2019)

Clinical factors associated with severe hypophosphataemia after kidney transplant
por: Ralston, Maximilian R., et al.
Publicado: (2021)

Life-threatening hypophosphataemia in a cirrhotic patient with jaundice
por: Moutzouri, Elisavet, et al.
Publicado: (2011)

Hypophosphataemia among Severely-malnourished Children: Case Series
por: Yoshimatsu, Shoji, et al.
Publicado: (2012)

Left Ventricular Hypertrophy in Patients with X-Linked Hypophosphataemia
por: Castellano-Martinez, Ana, et al.
Publicado: (2022)

Bone Canopies in Pediatric Renal Osteodystrophy
por: Pereira, Renata C., et al.
Publicado: (2016)

Cyst-like Tumors in Renal Osteodystrophy
por: Li Cavoli, Gioacchino, et al.
Publicado: (2021)

Treatment of hypophosphataemia in critically ill patients with a two day dosing regimen
por: Giles, LJ, et al.
Publicado: (2000)

Suboptimal Level of Bone‐Forming Cells in Advanced Cirrhosis are Associated with Hepatic Osteodystrophy
por: Bihari, Chhagan, et al.
Publicado: (2018)

Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment
por: Spirlandeli, Adriano L., et al.
Publicado: (2017)

C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signaling
por: Zhang, Dong Dong, et al.
Publicado: (2019)

Incidence, severity and timing of hypophosphataemia in Glasgow Royal Infirmary ICU
por: Gilhooly, CJ, et al.
Publicado: (2009)

Acute onset quadriparesis following oesophagectomy due to isolated hypophosphataemia
por: Naik, Vibhavari M, et al.
Publicado: (2019)

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
por: Haffner, Dieter, et al.
Publicado: (2019)

Correction of lower limb deformities in children with renal osteodystrophy by guided growth technique
por: Gigante, C., et al.
Publicado: (2017)

Prevalence of Renal Osteodystrophy in African Hemodialysis Patients
por: Bahad, Abdelaali, et al.
Publicado: (2013)

Correction: Bone Canopies in Pediatric Renal Osteodystrophy
por: Pereira, Renata C., et al.
Publicado: (2016)

Hepatic osteodystrophy and fracture risk prediction using FRAX tool in Indian patients with cirrhosis
por: De, Arka, et al.
Publicado: (2020)

Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD
por: Sharma, Shilpa, et al.
Publicado: (2019)

Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction
por: Ifie, Eseoghene, et al.
Publicado: (2019)

New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management
por: Saraff, Vrinda, et al.
Publicado: (2020)

Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

Divalent ion metabolism and osteodystrophy in chronic renal failure.
por: Kleeman, C. R., et al.
Publicado: (1967)

EXPERIMENTAL FIBROUS OSTEODYSTROPHY (OSTITIS FIBROSA) IN HYPERPARATHYROID DOGS
por: Jaffe, Henry L., et al.
Publicado: (1930)

Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy
por: Khwaja, Ansab, et al.
Publicado: (2015)

Recent Advances in the Non-invasive Diagnosis of Renal Osteodystrophy
por: Moorthi, Ranjani N, et al.
Publicado: (2013)

Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy
por: Bisson, Sarah-Kim, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cpf514t4ltctjq4q5jlf0ookh8